KRAS and familial pancreatic carcinoma: Importantly, integrative studies using clinical databases and genetically engineered mouse models showed that Kras mutation upregulated expression of FOSL1 to commit a transcriptional program including genes involved in mitosis progression to promote lung and pancreatic cancer progression 5,6.